These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25423891)

  • 1. Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development.
    Li Q; Foote M; Chen J
    Sci Rep; 2014 Nov; 4():7207. PubMed ID: 25423891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor valproic acid as a small molecule inducer to direct the differentiation of pluripotent stem cells.
    Chen J; Lacroix N; Li Q
    Methods Mol Biol; 2013; 977():359-63. PubMed ID: 23436377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
    Shi G; Gao F; Jin Y
    J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
    Kondo Y; Iwao T; Yoshihashi S; Mimori K; Ogihara R; Nagata K; Kurose K; Saito M; Niwa T; Suzuki T; Miyata N; Ohmori S; Nakamura K; Matsunaga T
    PLoS One; 2014; 9(8):e104010. PubMed ID: 25084468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
    De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
    Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice.
    Ono T; Li C; Mizutani E; Terashita Y; Yamagata K; Wakayama T
    Biol Reprod; 2010 Dec; 83(6):929-37. PubMed ID: 20686182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histone Deacetylase Inhibitors in the in Vitro Expansion of Hematopoietic Stem Cells].
    Chen M; Zhuang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):109-115. PubMed ID: 33663671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.
    Chen J; Li Q
    Methods Mol Biol; 2013; 977():353-7. PubMed ID: 23436376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
    Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
    PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors.
    Bhat J; Oberg HH; Kabelitz D
    Cell Immunol; 2015 Jul; 296(1):50-6. PubMed ID: 25708484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01.
    Schweinfurth N; Hohmann S; Deuschle M; Lederbogen F; Schloss P
    Platelets; 2010; 21(8):648-57. PubMed ID: 20942599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 1 and 3 regulate the mesodermal lineage commitment of mouse embryonic stem cells.
    Lv W; Guo X; Wang G; Xu Y; Kang J
    PLoS One; 2014; 9(11):e113262. PubMed ID: 25412078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
    Jeong SG; Ohn T; Kim SH; Cho GW
    Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells.
    Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C
    Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain.
    Shen S; Li J; Casaccia-Bonnefil P
    J Cell Biol; 2005 May; 169(4):577-89. PubMed ID: 15897262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.